Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2024

Magro CM, Kalomeris T, Shreve CR, Geyer JT, Patel SS. Subcutaneous panniculitic-like T-cell lymphoma localized to a site of peginterferon alfa-2a administration. Leuk Lymphoma. 2024:1-9.

Hu S, Graham RP, Choi W-, Wen KW, Putra J, Chen W, et al. Clinicopathologic Features of Gastrointestinal Tract Langerhans Cell Histiocytosis. Mod Pathol. 2024;37(9):100543.

Quaranta P, Basso-Ricci L, Hernández RJ, Pacini G, Naldini MM, Barcella M, et al. Circulating Hematopoietic Stem/Progenitor Cells subsets contribute to human hematopoietic homeostasis. Blood. 2024.

Conway J, Magro CM, Lipner SR. Expanding the Differential Diagnosis of the Painful Nail: A Case of an Onychopapilloma with Neuroma. Case Rep Dermatol. 2024;16(1):88-93.

Gal J, Mosquera JM, Robinson BD, Schlegel PN. Incidental seminoma in nonobstructive azoospermia: a case report. F S Rep. 2024;5(2):211-213.

O'Neill KA, Dugue A, Abreu NJ, Balcer LJ, Branche M, Galetta S, et al. Relapsing White Matter Disease and Subclinical Optic Neuropathy: From the National Multiple Sclerosis Society Case Conference Proceedings. Neurol Neuroimmunol Neuroinflamm. 2024;11(2):e200194.

Han Y, Duan X, Yang L, Nilsson-Payant BE, Wang P, Duan F, et al. Author Correction: Identification of SARS-CoV-2 inhibitors using lung and colonic organoids. Nature. 2024;630(8016):E7.

Smimmo M, Casale V, Casillo GM, Mitidieri E, Bianca Rd, Bello I, et al. Hydrogen sulfide dysfunction in metabolic syndrome-associated vascular complications involves cGMP regulation through soluble guanylyl cyclase persulfidation. Biomed Pharmacother. 2024;174:116466.

Caplan AS, Todd GC, Zhu YC, Sikora M, Akoh CC, Jakus J, et al. Clinical Course, Antifungal Susceptibility, and Genomic Sequencing of Trichophyton indotineae. JAMA Dermatol. 2024;160(7):701-709.

Barisic D, Chin CR, Meydan C, Teater M, Tsialta I, Mlynarczyk C, et al. ARID1A orchestrates SWI/SNF-mediated sequential binding of transcription factors with ARID1A loss driving pre-memory B cell fate and lymphomagenesis. Cancer Cell. 2024.